127 related articles for article (PubMed ID: 23726969)
1. Vascular endothelial growth factor as a biomarker for endostatin gene therapy.
Braga MS; Turaça TL; Foguer K; Chaves KC; Pesquero JB; Chammas R; Schor N; Bellini MH
Biomed Pharmacother; 2013 Jul; 67(6):511-5. PubMed ID: 23726969
[TBL] [Abstract][Full Text] [Related]
2. Fibronectin expression is decreased in metastatic renal cell carcinoma following endostatin gene therapy.
Chaves KC; Turaça LT; Pesquero JB; Mennecier G; Dagli ML; Chammas R; Schor N; Bellini MH
Biomed Pharmacother; 2012 Sep; 66(6):464-8. PubMed ID: 22920414
[TBL] [Abstract][Full Text] [Related]
3. Endostatin neoadjuvant gene therapy extends survival in an orthotopic metastatic mouse model of renal cell carcinoma.
de Souza Braga M; Chaves KB; Chammas R; Schor N; Bellini MH
Biomed Pharmacother; 2012 Jun; 66(4):237-41. PubMed ID: 22560459
[TBL] [Abstract][Full Text] [Related]
4. Endostatin gene therapy stimulates upregulation of ICAM-1 and VCAM-1 in a metastatic renal cell carcinoma model.
Chaves KC; Peron JP; Chammas R; Turaça LT; Pesquero JB; Braga MS; Foguer K; Schor N; Bellini MH
Cancer Gene Ther; 2012 Aug; 19(8):558-65. PubMed ID: 22699868
[TBL] [Abstract][Full Text] [Related]
5. Endostatin gene therapy inhibits intratumoral macrophage M2 polarization.
Foguer K; Braga Mde S; Peron JP; Bortoluci KR; Bellini MH
Biomed Pharmacother; 2016 Apr; 79():102-11. PubMed ID: 27044818
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the NF-кB/p50/Bcl-3 complex in response to antiangiogenic therapy in a mouse model of metastatic renal cell carcinoma.
de Souza Braga M; da Silva Paiva KB; Foguer K; Barbosa Chaves KC; de Sá Lima L; Scavone C; Bellini MH
Biomed Pharmacother; 2014 Sep; 68(7):873-9. PubMed ID: 25113400
[TBL] [Abstract][Full Text] [Related]
7. Endostatin/collagen XVIII--an inhibitor of angiogenesis--is expressed in cartilage and fibrocartilage.
Pufe T; Petersen WJ; Miosge N; Goldring MB; Mentlein R; Varoga DJ; Tillmann BN
Matrix Biol; 2004 Aug; 23(5):267-76. PubMed ID: 15464359
[TBL] [Abstract][Full Text] [Related]
8. Endostatin affects osteoblast behavior in vitro, but collagen XVIII/endostatin is not essential for skeletal development in vivo.
Sipola A; Seppinen L; Pihlajaniemi T; Tuukkanen J
Calcif Tissue Int; 2009 Nov; 85(5):412-20. PubMed ID: 19763371
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas.
Ding I; Sun JZ; Fenton B; Liu WM; Kimsely P; Okunieff P; Min W
Cancer Res; 2001 Jan; 61(2):526-31. PubMed ID: 11212245
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of vascular endothelial growth factor in renal cell carcinoma cells by glucocorticoids.
Iwai A; Fujii Y; Kawakami S; Takazawa R; Kageyama Y; Yoshida MA; Kihara K
Mol Cell Endocrinol; 2004 Oct; 226(1-2):11-7. PubMed ID: 15489000
[TBL] [Abstract][Full Text] [Related]
11. Endostatin inhibits nitric oxide and diminishes VEGF and collagen XVIII in squamous carcinoma cells.
Hebert C; Siavash H; Norris K; Nikitakis NG; Sauk JJ
Int J Cancer; 2005 Mar; 114(2):195-201. PubMed ID: 15540202
[TBL] [Abstract][Full Text] [Related]
12. Effect of peritoneal dialysis on expression of vascular endothelial growth factor, basic fibroblast growth factor and endostatin of the peritoneum in peritoneal dialysis patients.
Gao D; Zhao ZZ; Liang XH; Li Y; Cao Y; Liu ZS
Nephrology (Carlton); 2011 Nov; 16(8):736-42. PubMed ID: 21771176
[TBL] [Abstract][Full Text] [Related]
13. The combination of HSV-tk and endostatin gene therapy eradicates orthotopic human renal cell carcinomas in nude mice.
Pulkkanen KJ; Laukkanen JM; Fuxe J; Kettunen MI; Rehn M; Kannasto JM; Parkkinen JJ; Kauppinen RA; Pettersson RF; Yla-Herttuala S
Cancer Gene Ther; 2002 Nov; 9(11):908-16. PubMed ID: 12386829
[TBL] [Abstract][Full Text] [Related]
14. Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma.
Feldman AL; Alexander HR; Yang JC; Linehan WM; Eyler RA; Miller MS; Steinberg SM; Libutti SK
Cancer; 2002 Oct; 95(8):1637-43. PubMed ID: 12365010
[TBL] [Abstract][Full Text] [Related]
15. A murine vascular endothelial growth factor antibody inhibits in vivo growth of human Caki-I renal adenocarcinoma.
Dagnaes-Hansen F; Rasmussen LM; Tilton R; Denner L; Flyvbjerg A
Anticancer Res; 2003; 23(2B):1625-30. PubMed ID: 12820432
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group.
Schips L; Dalpiaz O; Lipsky K; Langner C; Rehak P; Puerstner P; Pummer K; Zigeuner R
Eur Urol; 2007 Jan; 51(1):168-73; discussion 174. PubMed ID: 16844285
[TBL] [Abstract][Full Text] [Related]
17. RNAi-mediated knockdown of vascular endothelial growth factor inhibits vascularization and tumor growth in renal cell carcinoma.
Gu M; Zhang K; Yao HJ; Zhou J; Peng YB; Xu MX; Wang Z
Int J Mol Med; 2015 Oct; 36(4):1063-72. PubMed ID: 26310563
[TBL] [Abstract][Full Text] [Related]
18. Endostatin down-regulates soluble guanylate cyclase (sGC) in endothelial cells in vivo: influence of endostatin on vascular endothelial growth factor (VEGF) signaling.
Schmidt A; Wenzel D; Thorey I; Werner S; Fleischmann BK; Bloch W
Endothelium; 2005; 12(5-6):251-7. PubMed ID: 16410224
[TBL] [Abstract][Full Text] [Related]
19. [Human endostatin antiangiogenic gene therapy mediated by recombinant adeno-associated virus vector in nude mouse with endometriosis].
Sun JJ; Yin LR; Mi RR; Ma HD; Guo SJ; Shi Y; Gu YJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):45-50. PubMed ID: 20367926
[TBL] [Abstract][Full Text] [Related]
20. Endostatin- and interleukin-2-expressing retroviral bicistronic vector for gene therapy of metastatic renal cell carcinoma.
Rocha FG; Calvo FB; Chaves KC; Peron JP; Marques RF; de Borba TR; Braga MS; Pereira CB; Vicente EJ; Chammas R; Schor N; Bellini MH
J Gene Med; 2011 Mar; 13(3):148-57. PubMed ID: 21344541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
